Skip to main content

Inotiv, Inc. (NOTV)

NASDAQ: NOTV · IEX Real-Time Price · USD
33.48 0.28 (0.83%)
Oct 21, 2021 2:59 PM EDT - Market open
Market Cap528.05M
Revenue (ttm)75.30M
Net Income (ttm)-5.15M
Shares Out14.66M
EPS (ttm)-0.43
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume59,535
Open32.30
Previous Close33.20
Day's Range32.06 - 33.97
52-Week Range4.85 - 50.33
Beta2.00
AnalystsBuy
Price Target64.50 (+92.7%)
Est. Earnings DateDec 21, 2021

About NOTV

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method ...

IndustryLife Sciences Tools & Services
IPO DateNov 24, 1997
CEORobert Leasure
Employees397
Stock ExchangeNASDAQ
Ticker SymbolNOTV
Full Company Profile

Financial Performance

In 2020, Inotiv's revenue was $60.47 million, an increase of 38.64% compared to the previous year's $43.62 million. Losses were -$4.69 million, 493.0% more than in 2019.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for Inotiv stock is "Buy." The 12-month stock price forecast is 64.50, which is an increase of 92.68% from the latest price.

Price Target
$64.50
(92.68% upside)
Analyst Consensus: Buy

News

Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.

WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and anal...

2 weeks ago - GlobeNewsWire

Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purch...

WEST LAFAYETTE, Ind., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

3 weeks ago - GlobeNewsWire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Inotiv, Inc. - NOTV

NEW YORK, Sept. 27, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Actio...

3 weeks ago - PRNewsWire

Inotiv Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Inotiv, Inc. Is Fair...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Inotiv, Inc. (NASDAQ: NOTV) and Envigo RMS Holding Corp. is fair to Inotiv sharehol...

4 weeks ago - Business Wire

Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering

WEST LAFAYETTE, Ind., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

4 weeks ago - GlobeNewsWire

Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering

WEST LAFAYETTE, Ind., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and an...

4 weeks ago - GlobeNewsWire

Inotiv Scoops Up Envigo For $200M To Enhance Research, Drug Discovery Solutions

Inotiv Inc (NASDAQ:NOTV), a contract research organization, has agreed to acquire Envigo RMS Holding Corp in a cash and stock transaction. Envigo is a provider of research models and services.

4 weeks ago - Benzinga

Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions

-- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions -- -- Expected to be immediately accretive to Inotiv earnings and margins before synergies --

1 month ago - GlobeNewsWire

Inotiv, Inc. to Participate in the 2021 Colliers Institutional Investor Conference

WEST LAFAYETTE, Ind., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and anal...

1 month ago - GlobeNewsWire

Inotiv: Q3 Earnings Insights

Shares of Inotiv (NASDAQ:NOTV) fell 1.0% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 87.50% year over year to ($0.15), which missed the ...

2 months ago - Benzinga

Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories

WEST LAFAYETTE, Ind., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and anal...

2 months ago - GlobeNewsWire

Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies

WEST LAFAYETTE, Ind., July 15, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV ) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and bi...

3 months ago - GlobeNewsWire

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma's BioReliance® portfolio

WEST LAFAYETTE, Ind., July 12, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and anal...

3 months ago - GlobeNewsWire

Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort

WEST LAFAYETTE, Ind., June 28, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and anal...

3 months ago - GlobeNewsWire

Inotiv Set to Join Russell 3000® Index and Russell 2000® Index

WEST LAFAYETTE, Ind., June 07, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and anal...

4 months ago - GlobeNewsWire

Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity

WEST LAFAYETTE, Ind., May 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analy...

4 months ago - GlobeNewsWire

Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results

WEST LAFAYETTE, Ind., May 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analy...

5 months ago - GlobeNewsWire

Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.

WEST LAFAYETTE, Ind., April 30, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

5 months ago - GlobeNewsWire

Inotiv, Inc. to Report Second Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021

WEST LAFAYETTE, Ind., April 26, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and an...

5 months ago - GlobeNewsWire

Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Sh...

WEST LAFAYETTE, Ind., April 23, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

5 months ago - GlobeNewsWire

Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares

WEST LAFAYETTE, Ind., April 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

6 months ago - GlobeNewsWire

Inotiv, Inc. Announces Proposed Public Offering of Common Shares

WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

6 months ago - GlobeNewsWire

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021

WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ana...

6 months ago - GlobeNewsWire

Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.

WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research services...

6 months ago - GlobeNewsWire

Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.

WEST LAFAYETTE, Ind., April 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research services,...

6 months ago - GlobeNewsWire